OCM
REGN icon

One Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

One Capital Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.3M Hold
22,368
– – 0.48% 47
2026
Q1 		$17.3M Buy
22,368
+743
+3% +$569K 0.47% 49
2025
Q4 		$16.7M Buy
21,625
+765
+4% +$520K 0.5% 45
2025
Q3 		$11.7M Buy
20,860
+1,140
+6% +$645K 0.37% 68
2025
Q2 		$10.4M Buy
19,720
+4,897
+33% +$2.73M 0.36% 72
2025
Q1 		$9.4M Buy
14,823
+2,337
+19% +$1.61M 0.32% 79
2024
Q4 		$8.89M Buy
12,486
+310
+3% +$260K 0.29% 88
2024
Q3 		$12.8M Buy
12,176
+508
+4% +$565K 0.41% 61
2024
Q2 		$12.3M Buy
11,668
+673
+6% +$652K 0.42% 56
2024
Q1 		$10.6M Buy
10,995
+25
+0.2% +$23.8K 0.38% 62
2023
Q4 		$9.63M Sell
10,970
-365
-3% -$301K 0.38% 63
2023
Q3 		$9.33M Buy
11,335
+480
+4% +$377K 0.41% 57
2023
Q2 		$7.8M Buy
10,855
+289
+3% +$223K 0.35% 68
2023
Q1 		$8.68M Sell
10,566
-56
-0.5% -$42.2K 0.43% 58
2022
Q4 		$7.66M Sell
10,622
-422
-4% -$311K 0.41% 66
2022
Q3 		$7.61M Buy
11,044
+487
+5% +$307K 0.45% 59
2022
Q2 		$6.24M Buy
10,557
+38
+0.4% +$24.7K 0.37% 71
2022
Q1 		$7.35M Buy
10,519
+144
+1% +$91.1K 0.39% 64
2021
Q4 		$6.55M Sell
10,375
-205
-2% -$126K 0.5% 50
2021
Q3 		$6.4M Sell
10,580
-643
-6% -$399K 0.53% 38
2021
Q2 		$6.27M Buy
11,223
+908
+9% +$460K 0.56% 41
2021
Q1 		$4.88M Buy
10,315
+1,251
+14% +$609K 0.54% 53
2020
Q4 		$4.38M Buy
9,064
+196
+2% +$106K 0.53% 55
2020
Q3 		$4.96M Sell
8,868
-177
-2% -$107K 0.68% 33
2020
Q2 		$5.64M Sell
9,045
-971
-10% -$551K 0.81% 28
2020
Q1 		$4.89M Buy
10,016
+811
+9% +$335K 0.83% 25
2019
Q4 		$3.46M Buy
+9,205
New +$3.1M 0.53% 48

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

One Capital Management's REGN Position: Q2 2026 in Review

One Capital Management held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 22,368 shares worth $17.3M. The position accounts for 0.48% of the portfolio, ranked #47.

One Capital Management first reported a position in REGN in Q4 2019 and has held it in 27 quarters since. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • One Capital Management held 22,368 shares of Regeneron Pharmaceuticals worth $17.3M as of Q2 2026.
  • One Capital Management left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.48% of One Capital Management's portfolio in Q2 2026, its #47 holding.
  • One Capital Management first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
  • 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on One Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.